Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The metabolism of chylomicrons and their remnants is a highly facilitated route to distribute energy from the diet for storage in adipose tissue or immediate use in the muscles. It has been proposed that chylomicron remnants are atherogenic, and a delayed clearance of chylomicron remnants seems to be associated with compositional abnormalities of other cholesterol-rich lipoproteins. Furthermore, the plasma concentration of chylomicron remnants is very low compared with all other major lipoprotein species. These arguments suggest that the metabolism of chylomicrons may not be directly implicated in atherogenesis, but it may instead enhance the atherogenicity of endogenous lipoproteins. This review critically examines the current literature in this field.


Journal article


Curr Opin Lipidol

Publication Date





123 - 129


Arteriosclerosis, Diabetes Mellitus, Food, Humans, Lipoproteins, Triglycerides